These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

165 related items for PubMed ID: 14693747

  • 1. Geographic excess of estrogen receptor-positive breast cancer.
    Benz CC, Clarke CA, Moore DH.
    Cancer Epidemiol Biomarkers Prev; 2003 Dec; 12(12):1523-7. PubMed ID: 14693747
    [Abstract] [Full Text] [Related]

  • 2. Regional variations in breast cancer incidence among California women, 1988-1997.
    Reynolds P, Hurley SE, Quach AT, Rosen H, Von Behren J, Hertz A, Smith D.
    Cancer Causes Control; 2005 Mar; 16(2):139-50. PubMed ID: 15868455
    [Abstract] [Full Text] [Related]

  • 3. Differences in breast cancer hormone receptor status and histology by race and ethnicity among women 50 years of age and older.
    Li CI, Malone KE, Daling JR.
    Cancer Epidemiol Biomarkers Prev; 2002 Jul; 11(7):601-7. PubMed ID: 12101106
    [Abstract] [Full Text] [Related]

  • 4. Risk factors for hormone receptor-defined breast cancer in postmenopausal women.
    Rosenberg LU, Einarsdóttir K, Friman EI, Wedrén S, Dickman PW, Hall P, Magnusson C.
    Cancer Epidemiol Biomarkers Prev; 2006 Dec; 15(12):2482-8. PubMed ID: 17164374
    [Abstract] [Full Text] [Related]

  • 5. Risk of invasive breast carcinoma among women diagnosed with ductal carcinoma in situ and lobular carcinoma in situ, 1988-2001.
    Li CI, Malone KE, Saltzman BS, Daling JR.
    Cancer; 2006 May 15; 106(10):2104-12. PubMed ID: 16604564
    [Abstract] [Full Text] [Related]

  • 6. Recent trends in breast cancer incidence rates by age and tumor characteristics among U.S. women.
    Jemal A, Ward E, Thun MJ.
    Breast Cancer Res; 2007 May 15; 9(3):R28. PubMed ID: 17477859
    [Abstract] [Full Text] [Related]

  • 7. Recreational physical activity and risk of postmenopausal breast cancer based on hormone receptor status.
    Bardia A, Hartmann LC, Vachon CM, Vierkant RA, Wang AH, Olson JE, Sellers TA, Cerhan JR.
    Arch Intern Med; 2007 May 15; 166(22):2478-83. PubMed ID: 17159013
    [Abstract] [Full Text] [Related]

  • 8. Breast cancer as heterogeneous disease: contributing factors and carcinogenesis mechanisms.
    Kravchenko J, Akushevich I, Seewaldt VL, Abernethy AP, Lyerly HK.
    Breast Cancer Res Treat; 2011 Jul 15; 128(2):483-93. PubMed ID: 21225455
    [Abstract] [Full Text] [Related]

  • 9. Progesterone and estrogen receptors and mammary neoplasia in the Iowa Women's Health Study: how many kinds of breast cancer are there?
    Potter JD, Cerhan JR, Sellers TA, McGovern PG, Drinkard C, Kushi LR, Folsom AR.
    Cancer Epidemiol Biomarkers Prev; 1995 Jun 15; 4(4):319-26. PubMed ID: 7655325
    [Abstract] [Full Text] [Related]

  • 10. Bilateral risk for subsequent breast cancer after lobular carcinoma-in-situ: analysis of surveillance, epidemiology, and end results data.
    Chuba PJ, Hamre MR, Yap J, Severson RK, Lucas D, Shamsa F, Aref A.
    J Clin Oncol; 2005 Aug 20; 23(24):5534-41. PubMed ID: 16110014
    [Abstract] [Full Text] [Related]

  • 11. Estrogen receptor-negative breast cancer is less likely to arise among lipophilic statin users.
    Kumar AS, Benz CC, Shim V, Minami CA, Moore DH, Esserman LJ.
    Cancer Epidemiol Biomarkers Prev; 2008 May 20; 17(5):1028-33. PubMed ID: 18463402
    [Abstract] [Full Text] [Related]

  • 12. Age-specific incidence rates of in situ breast carcinomas by histologic type, 1980 to 2001.
    Li CI, Daling JR, Malone KE.
    Cancer Epidemiol Biomarkers Prev; 2005 Apr 20; 14(4):1008-11. PubMed ID: 15824180
    [Abstract] [Full Text] [Related]

  • 13. Risk factors for estrogen receptor-positive breast cancer.
    Hwang ES, Chew T, Shiboski S, Farren G, Benz CC, Wrensch M.
    Arch Surg; 2005 Jan 20; 140(1):58-62. PubMed ID: 15655207
    [Abstract] [Full Text] [Related]

  • 14. [Immunohistochemical investigation of steroid hormones (ER, PR) in breast cancer].
    Mchedlishvili MIu, Gabunia UA, Makharoblidze ER, Burnadze KT, Piradashvili DZ.
    Georgian Med News; 2005 Feb 20; (119):65-7. PubMed ID: 15834186
    [Abstract] [Full Text] [Related]

  • 15. Changing incidence rate of invasive lobular breast carcinoma among older women.
    Li CI, Anderson BO, Porter P, Holt SK, Daling JR, Moe RE.
    Cancer; 2000 Jun 01; 88(11):2561-9. PubMed ID: 10861434
    [Abstract] [Full Text] [Related]

  • 16. Age-related lobular involution and risk of breast cancer.
    Milanese TR, Hartmann LC, Sellers TA, Frost MH, Vierkant RA, Maloney SD, Pankratz VS, Degnim AC, Vachon CM, Reynolds CA, Thompson RA, Melton LJ, Goode EL, Visscher DW.
    J Natl Cancer Inst; 2006 Nov 15; 98(22):1600-7. PubMed ID: 17105983
    [Abstract] [Full Text] [Related]

  • 17. Correlation of her-2/neu gene amplification with other prognostic and predictive factors in female breast carcinoma.
    Ariga R, Zarif A, Korasick J, Reddy V, Siziopikou K, Gattuso P.
    Breast J; 2005 Nov 15; 11(4):278-80. PubMed ID: 15982396
    [Abstract] [Full Text] [Related]

  • 18. Dissemination of adjuvant multiagent chemotherapy and tamoxifen for breast cancer in the United States using estrogen receptor information: 1975-1999.
    Mariotto AB, Feuer EJ, Harlan LC, Abrams J.
    J Natl Cancer Inst Monogr; 2006 Nov 15; (36):7-15. PubMed ID: 17032888
    [Abstract] [Full Text] [Related]

  • 19. Comparison of triple-negative and estrogen receptor-positive/progesterone receptor-positive/HER2-negative breast carcinoma using quantitative fluorine-18 fluorodeoxyglucose/positron emission tomography imaging parameters: a potentially useful method for disease characterization.
    Basu S, Chen W, Tchou J, Mavi A, Cermik T, Czerniecki B, Schnall M, Alavi A.
    Cancer; 2008 Mar 01; 112(5):995-1000. PubMed ID: 18098228
    [Abstract] [Full Text] [Related]

  • 20. Regional differences in the incidence and treatment of carcinoma in situ of the breast.
    Choi WS, Parker BA, Pierce JP, Greenberg ER.
    Cancer Epidemiol Biomarkers Prev; 1996 Apr 01; 5(4):317-20. PubMed ID: 8722225
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.